Transcriptome Profiling of Prostate Cancer

Transcriptome Profiling of Prostate Cancer, Considering Risk ...

In this study, we performed RNA-Seq profiling of 58 localized PCa and 43 locally advanced PCa tissue samples obtained as a result of radical prostatectomy on a ...

Transcriptome Profiling of Prostate Cancer, Considering Risk ...

Molecular heterogeneity in prostate cancer (PCa) is one of the key reasons underlying the differing likelihoods of recurrence after surgical ...

Dynamic prostate cancer transcriptome analysis delineates ... - Nature

We show that tumor progression occurs through transcriptional adaption rather than a selection of pre-existing cancer cell clusters.

Longitudinal Prostate Cancer Transcriptomic and Clinical Data ...

Importance Although tissue-based gene expression testing has become widely used for prostate cancer risk stratification, its prognostic ...

Tumor transcriptomic profiling of patients (pts) with metastatic ...

Tumor transcriptomic profiling of patients (pts) with metastatic castration sensitive prostate cancer (mCSPC) who do versus who do not achieve ...

Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical ...

A tailored PCa gene panel allowed us to stratify metastatic castration-resistant prostate cancer (mCRPC) patients with clinical outcomes. In ...

Whole-genome and Transcriptome Sequencing of Prostate Cancer ...

The study sequenced whole-genome and transcriptome of tumor-benign paired tissues from 65 treatment-naive Chinese PCa patients.

Global Transcriptome Analysis of Formalin-Fixed Prostate Cancer ...

Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence.

Transcriptome-wide prediction of prostate cancer gene expression ...

We conducted the first transcriptome-wide analysis in prostate cancer, using CNNs to predict bulk RNA-sequencing estimates from WSIs for 370 patients from the ...

Integrative metabolic and transcriptomic profiling of prostate cancer ...

Reactive stroma is a tissue feature commonly observed in the tumor microenvironment of prostate cancer and has previously been associated ...

Spatial whole transcriptome profiling of primary tumor from patients ...

Prostate cancer (PCa) is a highly heterogeneous disease in terms of its molecular makeup and clinical prognosis. The prostate tumor ...

Microbiota of the prostate tumor environment investigated by whole ...

Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling ... analysis of public cancer genome sequence data.

Transcriptome profiling of prostate tissue samples from early onset ...

Transcriptome profiling of prostate tissue samples from early onset prostate cancer patients and normal controls by RNA-seq · 1 sample · DAC: EGAC00001000279 ...

Identification of Messenger RNA Isoform Signatures in Prostate ...

Although classic approaches based on gene expression profiling have revealed many potential cancer biomarkers, several studies indicate that tumor-specific mRNA ...

Transcriptomic profiling of urine extracellular vesicles reveals ...

Here we show that urinary EV (uEV) from prostate cancer (PCa) patients exhibit genuine and differential physical and biological properties compared to benign ...

Genomic, epigenomic, and transcriptomic signatures of prostate ...

Overall, we observed that the genomic, epigenomic, and transcriptomic alterations evaluated between AA and EA prostate cancer patients varied between studies, ...

Article Integrative Genomic Profiling of Human Prostate Cancer

We present an integrated oncogenomic analysis of 218 primary and metastatic prostate cancers as well as 12 cell lines and xenografts.

and post-treatment prostatic biopsies from patients with advanced ...

... transcriptome profiling of pre- and post-treatment prostatic biopsies from patients with advanced hormone-naive prostate cancer treated with ...

Transcriptome Analysis Identifies Tumor Immune Microenvironment ...

Prostate cancer (PCa) is the second most common cause of cancer death in American men. Metastatic castration-resistant prostate cancer ...

Longitudinal transcriptome profiling of localized hormone-sensitive ...

5026Background: The ENACT trial (NCT02799745) randomized men with low- or intermediate-risk prostate cancer to 12 months of ENZA monotherapy followed by ...